Wuhan General Group (China), Inc. Stock Other OTC
Equities
WUHN
US9825691051
Biotechnology & Medical Research
Sales 2011 | 128M 174M | Sales 2012 | 80.38M 110M | Capitalization | 1.33M 1.82M |
---|---|---|---|---|---|
Net income 2011 | -3M -4.1M | Net income 2012 | -10M -13.67M | EV / Sales 2011 | 0.55 x |
Net Debt 2011 | 62.49M 85.45M | Net Debt 2012 | 100M 137M | EV / Sales 2012 | 1.26 x |
P/E ratio 2011 |
-1.56
x | P/E ratio 2012 |
-0.12
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 76.65% |
Managers | Title | Age | Since |
---|---|---|---|
Jeff Robinson
FOU | Founder | - | 88-07-18 |
Willem Jonker
DFI | Director of Finance/CFO | - | 20-10-04 |
Riyad Domingo
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | - | 19-01-21 | |
Jeff Robinson
FOU | Founder | - | 88-07-18 |
1st Jan change | Capi. | |
---|---|---|
+26.58% | 44.96B | |
-0.81% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.46% | 26.08B | |
-21.10% | 19.03B | |
+6.14% | 12.75B | |
+28.25% | 12.06B | |
-3.30% | 11.75B |